MARIANN HABHAB: Open Payments
NPI 1568946325 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 34 payments from 7 companies in 2025. Trend: 2023 $248 · 2024 $301 · 2025 $993
Food & beverage: $909Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $270 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $215 |
| Aimmune Therapeutics, Inc. | 5 | $198 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $171 |
| Ardelyx, Inc. | 5 | $96 |
| QOL Medical, LLC | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
Products named: TREMFYA, XIFAXAN, ZENPEP, ENTYVIO, IBSRELA, Sucraid, RINVOQ, VOWST.
Industry payments across MI — which companies pay providers there.
